Automation Workflow for Synthetic Data Fidelity Validation & Scoring

Manual validation of synthetic data is a bottleneck that stalls research and introduces compliance risk. This automated workflow scores each generated cohort on statistical fidelity (e.g., KS tests, propensity scores), clinical logic consistency, and re-identification risk. It gates data release to downstream R&D teams, ensuring only cohorts that pass predefined thresholds for utility and safety are provisioned. The system directly addresses operational delays and the risk of deploying flawed synthetic data into sensitive model development or trial design pipelines.

Implementation integrates this validation layer with your synthetic data pipeline, using frameworks like LangGraph to orchestrate specialized validation agents. Each agent queries reference distributions from OMOP or EHR systems, applies domain-specific rules, and returns a scored metric. The orchestrator aggregates scores, checks against governance policies, and triggers actions: releasing data to a catalog like Purview, flagging for human review in ServiceNow, or initiating regeneration. Observability is built-in, with all scores, decisions, and overrides logged to an immutable audit trail for IRB and compliance reporting.

This orchestrator automates the critical bottleneck of validating synthetic patient cohorts against real-world statistical, clinical, and privacy benchmarks. It eliminates the manual, sample-based review that delays data release, creating a continuous validation layer that gates data flow to downstream R&D teams. The business value is direct: accelerated experimentation cycles, guaranteed data utility for model training, and enforceable privacy compliance, all while reducing the operational labor of data scientists and governance teams by over 70%.

Implementation integrates this agentic layer directly with your synthetic data pipeline (e.g., using Gretel, Syntegra, or custom GANs) and downstream systems like an OMOP CDM or research sandbox. The orchestrator, built on LangGraph or Temporal, manages state, handles retries, and enforces SLAs. Each specialized validation agent is a containerized service, scoring cohorts against predefined metrics; scores are logged to Datadog for observability. Approval gates are configurable per use case, and all failures are routed to a human-in-the-loop dashboard in ServiceNow or Jira for triage, ensuring no low-fidelity data escapes the pipeline.

Phase 1 establishes the core validation engine, integrating directly with your synthetic data pipeline (e.g., using Gretel, Mostly AI, or custom GANs). We instrument statistical tests (KS, propensity scores) and clinical logic checks against source EHR distributions. This initial layer produces fidelity scores and anomaly flags, providing immediate visibility into data quality drift and preventing flawed cohorts from advancing. The focus is on measurable baseline accuracy and integration with existing data catalogs and research platforms.

Phase 2 introduces automated governance and continuous optimization. Approval gates are configured based on score thresholds and intended use case (e.g., internal research vs. external sharing). Failed cohorts are routed to a human-in-the-loop dashboard for review, with linked diagnostics. The final phase operationalizes monitoring, tracking performance metrics like validation runtime and cohort rejection rates, and triggers automatic model retraining when fidelity drifts beyond set bounds. This creates a closed-loop system ensuring reliable, compliant data delivery.

This automated validation layer is a critical control point that gates the release of synthetic data to downstream R&D and model development teams. It directly addresses the operational bottleneck of manual, sample-based quality assurance, which is slow, inconsistent, and unscalable for high-volume generation pipelines. The business value comes from accelerating data delivery cycles while ensuring that only cohorts meeting predefined fidelity and privacy thresholds are approved for use, protecting research integrity and regulatory compliance. Implementation requires integrating validation agents with the synthetic data pipeline, clinical knowledge bases, and data catalogs.

Effective rollout requires a phased approach, starting with non-critical research sandboxes before progressing to regulated development environments. Initial controls focus on basic statistical metrics (KS tests, propensity scores), with subsequent phases adding complex clinical plausibility checks and automated re-identification risk testing. Monitoring is built into the orchestrator, tracking validation failure rates, compute cost per cohort, and drift in fidelity scores to trigger model retraining. This governance framework, integrated with platforms like Collibra or Alation, creates an auditable, self-improving system that operationalizes trust in synthetic data assets at scale.